Peripheral Artery Disease
Novel implant for below-the-knee treatment of CLTI gains breakthrough device designation
Elixir Medical announced it received breakthrough device designation FDA for its novel adaptive implant for the treatment of narrowed or blocked below-the-knee vessels in patients with chronic limb-threatening ischemia.
Smoking, high BMI drive relationship between PAD, major depressive disorder
The elevated propensity for peripheral artery disease in patients with major depression may be mediated by increased liability for lifetime smoking and BMI, according to research in the Journal of the American Heart Association.
FDA grants device for treatment of chronic limb-threatening ischemia breakthrough status
Efemoral Medical announced the FDA granted breakthrough device status to its vascular scaffold system for treatment of de novo or restenotic lesions of the infrapopliteal arteries in patients with chronic limb-threatening ischemia.
FDA clears radial access catheter for atherectomy in peripheral artery disease
AngioDynamics announced its 225 cm radial access catheter for use with the company’s atherectomy system received FDA 510(k) clearance for the treatment of peripheral artery disease.
High Lp(a) common in patients undergoing CABG; linked to poor outcomes
High lipoprotein(a), a relatively common finding in patients undergoing CABG, was associated with increased risk for all-cause death after surgery, researchers reported.
Obesity management, teplizumab guidance among updates in ADA 2024 Standards of Care
New guidance on obesity management and cardiovascular disease screening for people with diabetes are among the updates in the American Diabetes Association’s 2024 Standards of Care.
Novel bioabsorbable scaffold for tibial vessels safe in first-in-human study
A novel bioabsorbable scaffold for tibial vessels was safe and associated with a low rate of restenosis in patients with Rutherford class 3, 4 or 5 peripheral artery disease, according to the results of a first-in-human study.
PAD intervention via radial access successful, safe in small multicenter cohort
Endovascular treatment of peripheral artery disease via radial access was feasible and safe in a small multicenter cohort, with only one patient requiring conversion to femoral access during, researchers reported.
Meta-analysis supports benefits of home-based walking exercise in patients with PAD
In patients with peripheral artery disease, home-based walking exercise improved 6-minute walk distance more than supervised treadmill exercise, according to the results of a meta-analysis.
In PAD, improvements greatest during first 2 months of supervised exercise training
In patients with peripheral artery disease who underwent a 3-month supervised exercise training program, the greatest improvements in functional performance occurred during the first 2 months, researchers reported.